- Report
- January 2026
- 198 Pages
Global
From €3206EUR$3,545USD£2,768GBP
€3562EUR$3,939USD£3,076GBP
- Report
- March 2025
- 182 Pages
Global
From €4069EUR$4,500USD£3,514GBP
- Report
- March 2026
- 196 Pages
Global
From €5290EUR$5,850USD£4,568GBP
- Report
- January 2026
- 195 Pages
Global
From €3206EUR$3,545USD£2,768GBP
€3562EUR$3,939USD£3,076GBP
- Report
- August 2025
- 183 Pages
Global
From €3206EUR$3,545USD£2,768GBP
€3562EUR$3,939USD£3,076GBP
- Report
- August 2025
- 187 Pages
Global
From €3206EUR$3,545USD£2,768GBP
€3562EUR$3,939USD£3,076GBP
- Report
- February 2026
- 250 Pages
Global
From €4060EUR$4,490USD£3,506GBP
- Report
- February 2026
- 250 Pages
Global
From €4060EUR$4,490USD£3,506GBP
- Report
- February 2026
- 250 Pages
Global
From €4060EUR$4,490USD£3,506GBP
- Report
- March 2026
- 480 Pages
Global
From €5290EUR$5,850USD£4,568GBP
- Report
- November 2025
- 160 Pages
Global
From €3572EUR$3,950USD£3,084GBP
- Report
- October 2025
- 160 Pages
Global
From €3572EUR$3,950USD£3,084GBP
- Report
- January 2025
- 768 Pages
Global
From €4340EUR$4,799USD£3,747GBP
- Report
- January 2025
- 120 Pages
Global
From €5380EUR$5,950USD£4,646GBP
- Report
- October 2023
- 145 Pages
Global
From €2848EUR$3,150USD£2,460GBP
- Report
- January 2023
- 115 Pages
Global
From €4069EUR$4,500USD£3,514GBP
- Report
- August 2023
- 95 Pages
Global
From €3500EUR$4,146USD£3,128GBP
- Report
- November 2021
- 802 Pages
Global
From €4521EUR$5,000USD£3,904GBP

The Expression Vector market is a subset of the genomics industry that focuses on the development and production of expression vectors. Expression vectors are DNA molecules used to introduce a gene of interest into a host organism, allowing for the expression of the gene's product. Expression vectors are used in a variety of applications, including gene therapy, protein production, and gene knockdown.
The Expression Vector market is highly competitive, with a variety of companies offering a range of products and services. Companies in the market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Promega Corporation, and OriGene Technologies. Show Less Read more